Jenny Brown, NP
Adult Health · Los Angeles, CANPI 1063983088
Payments from drug & device makers
Across 84 payments — averaging $16.02 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Amgen$209
- AbbVie$182
- Amarin Pharma, Inc.$166
- Lilly USA, LLC$122
- Novo Nordisk$118
- Boehringer Ingelheim$89
- plus $460 from 13 others
What the payments were for
- Food & beverage$1,346100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Amgen | 11 | $209 |
| AbbVie(2 entities) | 16 | $182 |
| Amarin Pharma, Inc. | 11 | $166 |
| Lilly USA, LLC | 8 | $122 |
| Novo Nordisk | 7 | $118 |
| Boehringer Ingelheim | 5 | $89 |
| Novartis | 4 | $72 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 4 | $65 |
| Biohaven Pharmaceuticals, Inc. | 3 | $51 |
| Johnson & Johnson | 2 | $42 |
| Exact Sciences | 2 | $39 |
| Pfizer | 2 | $38 |
| AstraZeneca | 2 | $37 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $30 |
| Ferring Pharmaceuticals Inc. | 1 | $21 |
| VBI Vaccine (delaware) Inc. | 1 | $21 |
| Bayer | 1 | $16 |
| Esperion Therapeutics, Inc. | 1 | $15 |
| Medtronic | 1 | $14 |
How this compares
$1,346 in reported general payments places this provider in the 75th percentile of 785 adult health providers in California.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Atorvastatin Calcium | 39 | $333 |
| Omeprazole | 32 | $331 |
| Pantoprazole Sodium | 11 | $166 |
| Levetiracetam | 31 | $160 |
| Levothyroxine Sodium | 15 | $141 |
| Lisinopril | 35 | $135 |
| Donepezil Hcl | 13 | $104 |
| Metformin Hcl | 15 | $88 |
| Fluoxetine Hcl | 30 | $61 |
| Amlodipine Besylate | 18 | $35 |
Paid to pharmacies, not to this prescriber.
Other adult health in Los Angeles
- Karolina FaysmanLos Angeles$1.1M
- Linda BuckLos Angeles$170K
- Lisa HinemanLos Angeles$29K
- Tammy HarperLos Angeles$11K
- Jennifer LettsomeLos Angeles$6K
- Melissa LeeLos Angeles$5K
- Jamie YoonLos Angeles$5K
- Siok-Hian Tay-KelleyStanford$611K
- Naomi PesynaAnaheim$141K
- Stacy GrissenEncinitas$82K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.